Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiko Ihara

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 10, 2006
[AII and inflammation]Yoshiko Ihara, Kensuke Egashira
Atherosclerosis|November 28, 2006
Catheter-based adenovirus-mediated anti-monocyte chemoattractant gene therapy attenuates in-stent neointima formation in cynomolgus monkeysKaku Nakano, Kensuke Egashira, Kisho Ohtani, et al.
Hypertension (Dallas, Tex. : 1979)|August 31, 2006
Angiotensin II type 1 receptor blockade attenuates in-stent restenosis by inhibiting inflammation and progenitor cellsKisho Ohtani, Kensuke Egashira, Yoshiko Ihara, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 31, 2008
Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosisJun-ichiro Koga, Kensuke Egashira, Tetsuya Matoba, et al.
Circulation|November 30, 2006
Stent-based local delivery of nuclear factor-kappaB decoy attenuates in-stent restenosis in hypercholesterolemic rabbitsKisho Ohtani, Kensuke Egashira, Kaku Nakano, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 22, 2007
Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeysKensuke Egashira, Kaku Nakano, Kisho Ohtani, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 28, 2004
Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic miceMinako Ishibashi, Kensuke Egashira, Qingwei Zhao, et al.
Journal of Molecular and Cellular Cardiology|September 1, 2007
Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosisYoshiko Ihara, Kensuke Egashira, Kaku Nakano, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 10, 2006
[AII and inflammation]Yoshiko Ihara, Kensuke Egashira
Atherosclerosis|November 28, 2006
Catheter-based adenovirus-mediated anti-monocyte chemoattractant gene therapy attenuates in-stent neointima formation in cynomolgus monkeysKaku Nakano, Kensuke Egashira, Kisho Ohtani, et al.
Hypertension (Dallas, Tex. : 1979)|August 31, 2006
Angiotensin II type 1 receptor blockade attenuates in-stent restenosis by inhibiting inflammation and progenitor cellsKisho Ohtani, Kensuke Egashira, Yoshiko Ihara, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 31, 2008
Essential role of angiotensin II type 1a receptors in the host vascular wall, but not the bone marrow, in the pathogenesis of angiotensin II-induced atherosclerosisJun-ichiro Koga, Kensuke Egashira, Tetsuya Matoba, et al.
Circulation|November 30, 2006
Stent-based local delivery of nuclear factor-kappaB decoy attenuates in-stent restenosis in hypercholesterolemic rabbitsKisho Ohtani, Kensuke Egashira, Kaku Nakano, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 22, 2007
Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeysKensuke Egashira, Kaku Nakano, Kisho Ohtani, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 28, 2004
Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic miceMinako Ishibashi, Kensuke Egashira, Qingwei Zhao, et al.
Journal of Molecular and Cellular Cardiology|September 1, 2007
Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosisYoshiko Ihara, Kensuke Egashira, Kaku Nakano, et al.
Pageof 1